Faruqi & Faruqi, LLP is Investigating UnitedHealth Group Incorporated (UNH) on Behalf of its Shareholders

Ein Arzt mit einem Tablet. (Symbolfoto) © ismagilov/iStock / Getty Images Plus/Getty Images http://www.gettyimages.de/

PR Newswire

NEW YORK, Jan. 3, 2017

NEW YORK, Jan. 3, 2017 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential misconduct at UnitedHealth Group Incorporated ("United Health" or the "Company") (NYSE:UNH).

The investigation focuses on whether the Company's Board of Directors and its officers committed mismanagement and breached their fiduciary duties. On October 4, 2016, the first of several class action complaints was filed in the United States District Court, District of Minnesota, against United Health and several of its wholly-owned subsidiaries (the "United Health Defendants") alleging violations of (a) the Employee Retirement Income Security Act of 1974 ("ERISA"), (b) violations of state law and (c) violations of the Racketeering Influenced and Corrupt Organizations Act ("RICO"). The complaint alleged that the United Health Defendants required network pharmacies to charge insured patients unauthorized and excessive amounts for prescription drugs. The United Health Defendants "clawed back" these excessive payments by forcing the pharmacies to pay the unauthorized and excessive charges to the United Health Defendants after collecting them from the insureds.

Request more information now by clicking here: www.faruqilaw.com/UNH. There is no cost or obligation to you.

Take Action

If you currently own United Health stock and would like to discuss your legal rights, please visit www.faruqilaw.com/UNH. You can also contact us by calling Nina Varindani toll free at (212) 983-9330 or by sending an e-mail to nvarindani@faruqilaw.com. Faruqi & Faruqi, LLP also encourages anyone with information regarding United Health's conduct to contact the firm, including whistleblowers, former employees, shareholders and others.

Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.

FARUQI & FARUQI, LLP
685 3^rd Avenue, 26^th Floor
New York, NY 10017
Attn: Nina Varindani
nvarindani@faruqilaw.com
Telephone: (212) 983-9330

ARIVA.DE Börsen-Geflüster

Weiter aufwärts?

Kurzfristig positionieren in UnitedHealth Group
VQ5NDD	Ask: 5,65	Hebel: 4,21
mit moderatem Hebel		Zum Produkt

Vontobel

Den Basisprospekt sowie die Endgültigen Bedingungen und die Basisinformationsblätter erhalten Sie hier: VQ5NDD,. Beachten Sie auch die weiteren Hinweise zu dieser Werbung. Der Emittent ist berechtigt, Wertpapiere mit open end-Laufzeit zu kündigen.

Kurse

UnitedHealth Group

437,45 €

+4,34%

Attn: Stuart J. Guber
sguber@faruqilaw.com
Telephone: (215) 277-5770

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/faruqi--faruqi-llp-is-investigating-unitedhealth-group-incorporated-unh-on-behalf-of-its-shareholders-300384784.html

SOURCE Faruqi & Faruqi, LLP

Mehr Nachrichten zur UnitedHealth Group Aktie kostenlos abonnieren

E-Mail-Adresse

Benachrichtigungen von ARIVA.DE
(Mit der Bestellung akzeptierst du die Datenschutzhinweise)

Hinweis: ARIVA.DE veröffentlicht in dieser Rubrik Analysen, Kolumnen und Nachrichten aus verschiedenen Quellen. Die ARIVA.DE AG ist nicht verantwortlich für Inhalte, die erkennbar von Dritten in den „News“-Bereich dieser Webseite eingestellt worden sind, und macht sich diese nicht zu Eigen. Diese Inhalte sind insbesondere durch eine entsprechende „von“-Kennzeichnung unterhalb der Artikelüberschrift und/oder durch den Link „Um den vollständigen Artikel zu lesen, klicken Sie bitte hier.“ erkennbar; verantwortlich für diese Inhalte ist allein der genannte Dritte.